Medicine and Dentistry
Apoplexy
100%
Anticonvulsant
50%
Biological Marker
50%
Sex Difference
50%
Burnout Syndrome
50%
Monoclonal Antibody
50%
Emotional Stress
37%
Acute Stress
33%
Transformed Migraine
30%
Episodic Migraine
30%
Substance Use Disorder
27%
Cognition
25%
National Institutes of Health Stroke Scale
22%
Brain Ischemia
19%
Hazard Ratio
16%
Brain Infarction
13%
Reperfusion Therapy
11%
Thrombectomy
11%
Magnetic Resonance Imaging
11%
Calcitonin Gene Related Peptide
10%
Mental Disorder
9%
Mortality Rate
8%
Cerebral Hemorrhage
8%
Modified Rankin Scale
8%
Transient Ischemic Attack
8%
Electric Shock
8%
Kindling Model
8%
Pentylenetetrazol
8%
Sodium Valproate
8%
Provocation Test
8%
Evidence-Based Medicine
8%
Phenobarbital
8%
Controlled Clinical Trial
8%
Mean Arterial Pressure
7%
Physical Rehabilitation
5%
Health Care
5%
Plummer-Vinson Syndrome
5%
Rehabilitation Engineering
5%
Cross Sectional Study
5%
Blood Clot Lysis
5%
Neuroscience
Mental Disorder
83%
Longitudinal Study
50%
Headache
50%
Physical Dependence
50%
Posttraumatic Stress Disorder
50%
Mild Cognitive Impairment
50%
Anticonvulsant
50%
Phenytoin
50%
Cytochrome P450 2C9
50%
Status Epilepticus
50%
Monoclonal Antibody
50%
Electroencephalography
16%
Migraine
10%
Neuroscience
8%
Psychiatry
8%
Valproic Acid
8%
Kindling Model
8%
Phenobarbital
8%
Pentylenetetrazol
8%
Diplopia
5%
Ataxia
5%
Dysarthria
5%
Calcitonin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Anticonvulsive Agent
50%
Ovary Polycystic Disease
50%
Mild Cognitive Impairment
50%
Primary Headache
50%
Headache
50%
Prevalence
50%
Monoclonal Antibody
50%
Calcitonin Gene Related Peptide
10%
Pentetrazole
8%
Phenobarbital
8%
Electric Shock
8%
Provocation Test
8%
Sodium Valproate
8%
Controlled Clinical Trial
8%
Comorbidity
7%
Focal Epilepsy
7%
Cross-Sectional Study
7%
Headache and Facial Pain
7%
Lacosamide
6%
Pregabalin
6%
Tiagabine
6%
Felbamate
6%
Vigabatrin
6%
Gabapentin
6%
Topiramate
6%
Rufinamide
6%
Levetiracetam
6%